STAT3 and colonic neoplasm: Our study showed that EGCG inhibited colon-cancer-cell proliferation and migration in both primary SW480 cells and metastatic SW620 and LS411N cell lines by suppressing the promoter activity of STAT3 and downregulating the transcription of STAT3.